72351-59-8Relevant articles and documents
TRICYCLIC PYRIDONES AND PYRIMIDONES
-
Paragraph 0789; 0793-0794, (2021/06/26)
A compound of Formula (I) is provided: (I) where the variables are defined herein.
SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF
-
Page/Page column 35, (2018/03/01)
Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally delivered formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
QUINOLINE DERIVATIVES AS SMO INHIBITORS
-
Paragraph 0110; 0111, (2017/02/28)
Disclosed are quinoline derivatives as hedgehog pathway inhibitors, especially as SMO inhibitors. Compounds of the present invention can be used in treating diseases relating to hedgehog pathway including cancer.